# Y-Biologics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/y-biologics

- Industry: Biotechnology
- Headquarters: Daejeon, South Korea
- Website: www.ybiologics.com/kr
- Total disclosed funding: $26M
- Latest round: Series D (Sep 21, 2020)
- Investors on record: 11

## About

Based in Daejeon, South Korea, and founded in 2007, Y-Biologics Inc. operates as a biotechnology company involved in the research and development of antibody drugs and provides its clients with new drugs that reduce the propagation of cancerous cells. In December 2023, YBIOLOGICS raised KRW 13.5 billion in an IPO, selling 1.5 million shares at KRW 9,000 per share, within the expected price range of KRW 9,000 and KRW 11,000 on the KOSDAQ. As of 2022, the company is led by its CEOs Youngwoo Park and Jang Woo-ik and the firm is having an employee count of 71 employees. The firm is working on exploring antibodies to create new therapeutics. The antibiotic research and development company has developed YBL-006 which is an antibody immuno-anticancer drug, Alice is a technology that activates T-immune cells, and the activated T-immune cells immediately kill cancer cells. As of 2021, the firm has generated a total comprehensive income of KRW 17,070,885,026.

## Funding rounds

- Series D, Sep 21, 2020, $17M — Genexine, Inc., GI Innovation, Inc., KClavis Investment
- Series B, Apr 8, 2016, $8.7M — InterVest, E&Investment, Smilegate Investment, Kolon Investment, CJ Investment, Magna Investment, Time Folio Asset Management
- Seed, Oct 1, 2015, $0.1M — Korea Omega Investment Corp.

## Investors

- Korea Omega Investment Corp. (https://capitalatlas.ai/funds/korea-omega-investment-corp) — Seed
- InterVest (https://capitalatlas.ai/funds/intervest) — Series B
- E&Investment (https://capitalatlas.ai/funds/e-investment) — Series B
- Smilegate Investment (https://capitalatlas.ai/funds/smilegate-investment) — Series B
- Kolon Investment (https://capitalatlas.ai/funds/kolon-investment) — Series B
- CJ Investment (https://capitalatlas.ai/funds/cj-investment) — Series B
- Magna Investment (https://capitalatlas.ai/funds/magna-investment) — Series B
- Time Folio Asset Management — Series B
- Genexine, Inc. — Series D
- GI Innovation, Inc. — Series D
- KClavis Investment (https://capitalatlas.ai/funds/kclavis-investment) — Series D